These data suggest that GRY-RBP co-packages with A3C in the HBV viral nucleocapsid to significantly upregulate A3 C-to-T mutational activity on the HBV viral genome and lead to Kataegis-like hypermutation as observed in mutations associated with human cancer. This evidence concerns the gene TRAPPC11 and cancer.